Monoclonal antibodies: FDA authorizes new treatment


Elena Fomina/Getty Images
For the most up-to-date news and information about the coronavirus pandemic, visit the WHO and CDC websites.

On Friday, the US Food and Drug Administration authorized a new monoclonal antibody therapy that appears to work against the omicron variant of COVID-19.

Bebtelovimab, made by Eli Lilly, is authorized for use in patients 12…

Read more…

spot_imgspot_img

Latest news

MSNBC Is Finished

Related news

LEAVE A REPLY

Please enter your comment!
Please enter your name here